Zacks Investment Management Penumbra Inc Transaction History

Zacks Investment Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$240.69 - $338.77 $51,748 - $72,835	-215 Reduced 2.85%	7,322 $1.77 Million
Q2 2023 Aug 15, 2023	BUY	$271.54 - $344.06 $294,349 - $372,961	1,084 Added 16.8%	7,537 $2.59 Million
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $248,459 - $314,814	-915 Reduced 12.42%	6,453 $2.22 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $1.62 Million - $2.05 Million	7,368 New	7,368 $2.05 Million
Q3 2020 Nov 16, 2020	SELL	$185.27 - $238.73 $724,590 - $933,673	-3,911 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$153.32 - $191.72 $132,315 - $165,454	-863 Reduced 18.08%	3,911 $699,000
Q1 2020 May 15, 2020	BUY	$124.34 - $193.76 $593,599 - $925,010	4,774 New	4,774 $770,000
Q3 2019 Nov 14, 2019	SELL	$131.82 - $183.4 $379,246 - $527,641	-2,877 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$124.65 - $167.39 $358,618 - $481,581	2,877 New	2,877 $460,000
Q4 2018 Feb 14, 2019	SELL	$113.42 - $156.48 $218,560 - $301,536	-1,927 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$121.55 - $156.8 $234,226 - $302,153	1,927 New	1,927 $288,000

376

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.99B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.